TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Incidence rate of solicited AEs within 30 minutes after each dose of vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rate of grade 3 and higher AEs within 0-30 days after each dose of vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: shoulder functional activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change From Baseline in PACC-5 Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean change in gait and balance parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in motors parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent correct responses
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of primary hypoparathyroidism
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of congenital hypoparathyroidism
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of acquired hypoparathyroidism
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of secondary hypoparathyroidism
Endpoint domain: Mortality/survival
Primary endpoint: Social Responsiveness Scale, Adult Version
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Area Under the Plasma Concentration Verse Time Curve From Time Zero to the Time of Last Measurable Concentration (AUC0-last)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration Versus Time Curve Extrapolated to Infinity (AUC0-infinity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abnormal ECG readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Abnormal clinical laboratory tests results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abnormal physical examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abnormal ECOG performance status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain interference scale (BPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants with dose-limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Participants with Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Participants with treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of subjects who develop peptic ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Diabetic Retinopathy Severity Score (DRSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: Change in absolute global longitudinal strain value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Symptoms of preterm labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of AI models for lung sound detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rectal function scores (Wexner score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rectal function scores (LARS score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Quality of life Scale (EORTC QLQ-C30)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of life Scale (EORTC QLQ-CR38)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Early post-MI heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changing Quality of Life Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changing Self-Care Power
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Daily Life Activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Leuven-postprandial distress scale (LPDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 1 month objective response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3 month objective response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decolonization of MDR-GNB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Suicidal risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resilient behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Continue pregnancy more than 20 weeks gestation
Endpoint domain: Mortality/survival
Primary endpoint: Change in Tardive Dyskinesia Impact Scale (TDIS) total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Sheehan Disability Scale (SDS) Items 1, 2, and 3
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in EQ-visual analogue scale (EQ-VAS) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Response rate of patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: temporomandibular joint function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of circulating neutrophils in reverse migration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Development of any adverse events of Grade 3 or higher
Endpoint domain: Adverse events/effects
Primary endpoint: Development of adverse events of Grade 3 or higher attributed to the study vaccines
Endpoint domain: Adverse events/effects
Primary endpoint: Viral breakthrough to greater than 1,000 copies/ml
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of individuals with diabetes mellitus who have undergone examination and exploration of both feet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life of individuals with diabetes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of Force Development (RFD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Warwich-Edinburgh Mental Well-being Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The Medication Adherence Report Scale
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cardiac rehabilitation participation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Subjective Sleep Quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in blood biomarker profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Improvement in severity of food sensitivity symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clopidogrel active metabolite concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platelet response phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chemotherapy effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Executive Functioning - Eriksen Flanker Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Working Memory - WISC Digit Span
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amplitude of muscle contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Duration of muscle contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Plasma Concentration of Remimazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum creatinine of participant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Creatinine clearance of participant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Estimation of Acute kidney injury to participant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Blood urea nitrogen of participant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Pain control at 72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: coincidence rate
Endpoint domain: Mortality/survival
Primary endpoint: House Brackmann grading scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Body temperature measurement accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year Pneumococcus vaccination rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Edmonton Symptom Diagnostic Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hamilton Depression Scale Total Score Change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevention of acute respiratory infections (ARI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Local temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance traveled (kilometers)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caudate Atrophy Rate on volumetric MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of motor phenoconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Dual Task Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Implant Stability Quotient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance Short Physical Performance Battery (SPPB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: One Leg Balance (OLB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sedation related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: NOM failure prediction accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance to audit standards
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in blood ALT (Alanine-Aminotransferase)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of healing wound progress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Increased targeted behaviours
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from baseline social phobia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Knowledge of pregnant women about preeclampsia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitude of pregnant women towards preeclampsia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients achieving sustained response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: patellofemoral pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knee extensor/flexor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: recurrence of bile duct stone or cholangitis
Endpoint domain: Adverse events/effects
Primary endpoint: need for a nasobiliary tube
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: need for stents
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change from baseline mean arterial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area Under the Concentration-time Curve Over One Dosing Interval (AUC0-tau)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive serum conversions of anti-tetanus toxoid IgG antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Hypoglycemia Events
Endpoint domain: Adverse events/effects
Primary endpoint: Proprioceptive drift
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Medically-Attended Adverse Events (MAAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Abstinent From Vaping at Week 8
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in ECG parameters (PQ/PR, QRS, QT, QTcF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in forced vital capacity (FVC) in mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in Ki-67 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral catheter insertion-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Development of Diabetic Kidney Disease (DKD)
Endpoint domain: Mortality/survival
Primary endpoint: Occurrence of treatment-emergent serious adverse events (TESAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of treatment-emergent adverse events leading to permanent withdrawal
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of treatment-emergent infections
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in blood pressure in mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in heart rate as bpm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency and severity of unsolicited adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency and relatedness of serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency and severity of early onset adverse events of special interest
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency and severity of late onset adverse events of special interest
Endpoint domain: Adverse events/effects
Primary endpoint: CHIKV viremia
Endpoint domain: Physiological/clinical
Primary endpoint: HIV viral load
Endpoint domain: Physiological/clinical
Primary endpoint: preliminary antitumor response T3P
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: laboratory abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of correctly predicted cases of acute mesenteric ischaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Patient-oriented composite endpoint (POCE)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Thirst
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Inspiratory oxygen fraction (FiO2) in the hypopharynx
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Expiratory oxygen fraction (FeO2) in the hypopharynx
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Inspiratory fraction of carbon dioxide (FiCO2) in the hypopharynx
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Expiratory fraction of carbon dioxide (FeCO2) in the hypopharynx
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Efficacy of Low-Molecular-Weight Heparin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: time spent in different sleep stages (deep, light, REM, awake)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delirium Observation Scale (DOS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in stroke volume (ml) at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accuracy of management decisions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported confidence in diagnosis and management decisions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum postoperative pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Posttraumatic Stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Placebo corrected change from baseline in QTcF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Correlation in detection of sources of atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area under the Glucose Infusion Rate (GIR) - time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: First visual analog scale (VAS) pain score in the post-anesthesia care unit (PACU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total PACU opioid requirements
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Buccal Probing Pocket Depth (PD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mucosal recession at the buccal aspect of the implant site
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain (VAS scale)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Bleeding on probing
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of Adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Degree of Pelvic organ Prolapse (POP-Q)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency, severity, and effect of urine incontinence on quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of interval cancers
Endpoint domain: Mortality/survival
Primary endpoint: overall pelvic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mean early diastolic mitral annular velocity (mean e')
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diopter measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: current state of illness perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Visual Analog Scale (Fear)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visual Analog Scale (Anxiety)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in suicidality on the Ask Suicide-Screening Questions (ASQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in suicidal ideation and behavior on the Columbia-Suicide Severity Rating Scale (C-SSRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in lethality/medical damage of suicide attempt on the Medical Damage Lethality Rating Scale (MD-LRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in aspects of suicide intent on the Suicide Intent Scale (SIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients' adherence rate to Smart APS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: TMAD of tricuspid annulus during early relaxation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 6 minutes-walk distance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AFEQT questionnaire score improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: number of steps and distance walked per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse Childhood Events (ACE) score
Endpoint domain: Adverse events/effects
Primary endpoint: Staff well-being and mental health
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Staff retention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Teaching staff report of family involvement
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Effect on the Autoimmune System
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in spirometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in peak power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of treatment-emergent Serious Adverse Events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Time in Glucose Target Range (70-180 mg/dl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cumulative incidence of reactogenicity
Endpoint domain: Adverse events/effects
Primary endpoint: Adductor Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Adductor to abductor ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Structure and composition of gut microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes